GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
D

Diversified Healthcare Trust DHC · USD

Real Estate · US listing · 🇺🇸 United States

Compare

7.32

+4.27%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$1.54bn

FY2016FY2025

Net income

−$285.9m

FY2016FY2025

Free cash flow

−$19.6m

FY2016FY2025

Shareholders' equity

$1.67bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$1.54bn$1.50bn$1.41bn$1.28bn$1.38bn$1.63bn$1.04bn$1.12bn$1.07bn$1.06bn
Gross profit−$245.3m$256.4m$225.3m$174.5m$291.4m$394.9m$538.0m$665.4m$660.8m$656.1m
Research and development——$0$0$0$0$0$1$0$0
Operating income−$39.3m$229.9m$199.2m−$91.2m$416.5m$364.3m$501.0m$579.5m$557.1m$609.6m
Net income−$285.9m−$370.3m−$293.6m−$15.8m$174.5m−$139.5m−$88.2m$286.9m$147.6m$141.3m
Diluted earnings per share-1.19-1.54-1.23-0.070.73-0.59-0.371.210.620.60

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$4.36bn$5.14bn$5.45bn$6.00bn$6.62bn$6.48bn$6.65bn$7.16bn$7.29bn$7.23bn
Cash and short-term investments$121.8m$144.6m$245.9m$658.1m$634.8m$74.4m$37.4m$55.0m$31.2m$31.7m
Total liabilities$2.70bn$3.18bn$3.11bn$3.36bn$3.96bn$3.86bn$3.78bn$3.98bn$4.02bn$4.03bn
Debt$2.40bn$2.91bn$2.82bn$3.05bn$3.68bn$3.50bn$3.50bn$3.65bn$3.67bn$3.71bn
Shareholders' equity$1.67bn$1.96bn$2.34bn$2.64bn$2.66bn$2.62bn$2.74bn$3.18bn$3.28bn$3.20bn
Shares outstanding240m240m239m239m238m238m238m238m237m237m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−$19.6m$112.2m$10.5m−$40.4m−$63.3m$158.5m$265.8m$392.8m$407.1m$426.8m
Capital spending——−$235.0m−$299.4m−$227.6m−$185.6m−$18.8m−$99.1m−$221.4m−$292.9m
Free cash flow−$19.6m$112.2m−$224.5m−$339.7m−$290.9m−$27.0m$247.0m$293.7m$185.6m$133.9m
Dividends paid−$9.7m−$9.6m−$9.6m−$9.6m−$9.5m−$42.8m−$199.7m−$370.7m−$370.6m−$370.5m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$365.4m$366.5m$379.6m$388.7m$382.7m$386.9m$379.6m$373.6m
Gross profit−$40.6m−$49.9m−$51.5m$63.3m$70.1m$72.5m$64.2m$63.6m
Operating income−$518,000−$4.7m$74.3m−$114.0m−$42.9m$63.5m$62.9m$49.7m
Net income−$37.4m−$43.3m−$21.2m−$164.0m−$91.6m−$9.0m−$87.4m−$98.7m
Diluted earnings per share-0.16-0.18-0.09-0.68-0.38-0.04-0.36-0.41
Cash from operations$38.0m$8.0m−$20.0m−$49.0m$53.0m−$3.0m$18.0m$21.0m
Capital spending−$73.0m−$35.0m——−$34.0m−$39.0m−$66.0m−$47.0m
Free cash flow−$35.0m−$27.0m——$19.0m−$42.0m−$48.0m−$26.0m
Total assets$4.24bn$4.27bn$4.36bn$4.68bn$4.76bn$5.00bn$5.14bn$5.29bn
Cash and short-term investments$116.8m$121.8m$121.8m$201.4m$141.8m$302.6m$144.6m$256.5m
Debt$2.40bn$2.40bn$2.40bn$2.72bn$2.64bn$2.80bn$3.29bn$2.82bn
Shareholders' equity$1.58bn$1.62bn$1.67bn$1.69bn$1.85bn$1.95bn$1.96bn$2.05bn

Financial ratios

Data as of 2 Nov 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Gross margin-16.0%17.1%16.0%13.6%21.1%24.2%——
Operating margin-5.2%-3.7%-6.0%14.7%31.6%5.8%——
Net margin-18.6%-24.8%-20.8%-1.2%12.6%-8.5%——
Return on equity-17.2%-18.9%-12.6%-0.6%6.6%-5.3%——
Return on assets-6.6%-7.2%-5.4%-0.3%2.6%-2.2%——
Free cash flow yield——13.2%14.0%8.9%18.6%15.4%26.6%
Revenue growth2.8%6.0%9.9%-7.2%-15.2%56.9%——
Earnings growth-22.8%26.1%1761.1%-109.0%-225.1%58.0%——
Current ratio100.72x11.29x8.77x0.95x36.83x7.45x——
Debt to equity1.44x1.49x1.21x1.14x1.35x1.45x——
Equity ratio38.2%38.1%42.9%44.0%40.2%40.4%——
Interest coverage-0.39x-0.23x-0.44x0.90x1.71x0.47x——
R&D as a share of sales——0.0%0.0%0.0%0.0%0.0%0.0%
Buybacks as a share of market value-0.1%-0.3%-0.3%-0.2%-0.1%-0.1%——

Growth per year

Compound annual rate

3 years5 years10 years
Revenue6.2%-1.2%4.4%
Operating income-24.5%——
Net income162.7%15.4%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin0.4%7.2%12.5%30.2%
Operating margin6.3%5.2%12.3%25.9%
Net margin-21.6%-16.9%-10.6%-2.3%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-4.1-1.5-3.0-9.84.2-7.0-22.79.730.831.8
Price to sales0.80.40.60.10.50.61.92.54.24.3

Market value over time

30 Nov 2016 to 30 Oct 2026, in USD

$4.15bn$1.87bn

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return122%-34%444%-74%-40%-49%-34%-36%4%20%

Dividends and splits

Per share, in the currency the company pays

Paid for 27 years. Last went ex-dividend on 19 Oct 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year0.040.040.040.040.040.040.180.84

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.